CBIO logo

Catalyst Biosciences (CBIO) Cash From Operations

Annual CFO

-$33.10 M
+$50.66 M+60.48%

31 December 2022

CBIO Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

-$3.22 M
-$746.00 K-30.19%

30 September 2023

CBIO Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

-$13.38 M
+$4.06 M+23.28%

30 September 2023

CBIO TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBIO Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+60.5%+81.8%+84.0%
5 y5 years+24.1%+60.2%+69.3%

CBIO Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-123.9%-101.8%-108.3%

Catalyst Biosciences Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2023
-
-$3.22 M(+30.2%)
-$13.38 M(-23.3%)
June 2023
-
-$2.47 M(-60.2%)
-$17.44 M(-36.0%)
Mar 2023
-
-$6.22 M(+321.4%)
-$27.26 M(-17.6%)
Dec 2022
-$33.10 M(-60.5%)
-$1.48 M(-79.7%)
-$33.10 M(-32.9%)
Sept 2022
-
-$7.28 M(-40.8%)
-$49.30 M(-22.5%)
June 2022
-
-$12.29 M(+2.0%)
-$63.62 M(-11.0%)
Mar 2022
-
-$12.05 M(-31.8%)
-$71.45 M(-14.7%)
Dec 2021
-$83.75 M(+52.1%)
-$17.68 M(-18.2%)
-$83.75 M(-5.0%)
Sept 2021
-
-$21.60 M(+7.3%)
-$88.19 M(+10.8%)
June 2021
-
-$20.12 M(-17.4%)
-$79.60 M(+6.7%)
Mar 2021
-
-$24.36 M(+10.1%)
-$74.61 M(+35.5%)
Dec 2020
-$55.05 M(+26.2%)
-$22.11 M(+70.0%)
-$55.05 M(+34.2%)
Sept 2020
-
-$13.01 M(-14.1%)
-$41.02 M(+10.5%)
June 2020
-
-$15.14 M(+216.0%)
-$37.12 M(+11.0%)
Mar 2020
-
-$4.79 M(-40.8%)
-$33.45 M(-23.3%)
Dec 2019
-$43.61 M(+52.7%)
-$8.09 M(-11.1%)
-$43.61 M(-2.1%)
Sept 2019
-
-$9.10 M(-20.6%)
-$44.53 M(+4.9%)
June 2019
-
-$11.47 M(-23.3%)
-$42.46 M(+10.6%)
Mar 2019
-
-$14.96 M(+66.0%)
-$38.40 M(+34.5%)
Dec 2018
-$28.55 M(+43.2%)
-$9.01 M(+28.3%)
-$28.55 M(+10.4%)
Sept 2018
-
-$7.02 M(-5.3%)
-$25.86 M(+8.8%)
June 2018
-
-$7.41 M(+45.2%)
-$23.77 M(+14.5%)
Mar 2018
-
-$5.11 M(-19.2%)
-$20.75 M(+4.1%)
Dec 2017
-$19.94 M(+7.9%)
-$6.32 M(+28.2%)
-$19.94 M(+7.2%)
Sept 2017
-
-$4.93 M(+12.0%)
-$18.60 M(-1.0%)
June 2017
-
-$4.40 M(+2.6%)
-$18.78 M(+4.2%)
Mar 2017
-
-$4.29 M(-13.8%)
-$18.02 M(-2.4%)
Dec 2016
-$18.47 M(-3.4%)
-$4.98 M(-2.6%)
-$18.47 M(-0.9%)
Sept 2016
-
-$5.11 M(+40.3%)
-$18.64 M(+5.5%)
June 2016
-
-$3.64 M(-23.2%)
-$17.66 M(-9.0%)
Mar 2016
-
-$4.74 M(-7.7%)
-$19.41 M(+1.6%)
Dec 2015
-$19.12 M(-44.6%)
-$5.14 M(+24.4%)
-$19.12 M(+12.3%)
Sept 2015
-
-$4.13 M(-23.4%)
-$17.03 M(-17.2%)
June 2015
-
-$5.40 M(+21.4%)
-$20.57 M(-14.6%)
Mar 2015
-
-$4.45 M(+45.7%)
-$24.08 M(-30.2%)
Dec 2014
-$34.48 M
-$3.05 M(-60.2%)
-$34.48 M(-19.1%)
Sept 2014
-
-$7.67 M(-13.9%)
-$42.60 M(-4.6%)
June 2014
-
-$8.91 M(-40.0%)
-$44.64 M(-3.3%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$14.85 M(+32.9%)
-$46.14 M(+13.6%)
Dec 2013
-$40.61 M(-36.8%)
-$11.17 M(+15.0%)
-$40.61 M(-1.1%)
Sept 2013
-
-$9.71 M(-6.8%)
-$41.05 M(-1.7%)
June 2013
-
-$10.41 M(+11.7%)
-$41.74 M(-14.2%)
Mar 2013
-
-$9.32 M(-19.7%)
-$48.66 M(-24.3%)
Dec 2012
-$64.24 M(-23.3%)
-$11.60 M(+11.5%)
-$64.24 M(-12.2%)
Sept 2012
-
-$10.40 M(-40.0%)
-$73.17 M(-9.5%)
June 2012
-
-$17.34 M(-30.4%)
-$80.84 M(-6.6%)
Mar 2012
-
-$24.90 M(+21.3%)
-$86.57 M(+3.4%)
Dec 2011
-$83.72 M(-160.5%)
-$20.53 M(+13.5%)
-$83.72 M(+6.1%)
Sept 2011
-
-$18.08 M(-21.6%)
-$78.90 M(+1.4%)
June 2011
-
-$23.06 M(+4.6%)
-$77.81 M(+33.9%)
Mar 2011
-
-$22.05 M(+40.3%)
-$58.10 M(-142.0%)
Dec 2010
$138.30 M(-669.8%)
-$15.71 M(-7.5%)
$138.30 M(-2.8%)
Sept 2010
-
-$16.99 M(+407.3%)
$142.28 M(-11.8%)
June 2010
-
-$3.35 M(-101.9%)
$161.24 M(+2.1%)
Mar 2010
-
$174.35 M(-1586.7%)
$157.87 M(-750.4%)
Dec 2009
-$24.27 M(-14.1%)
-$11.73 M(-696.8%)
-$24.27 M(+39.7%)
Sept 2009
-
$1.97 M(-129.2%)
-$17.37 M(-37.1%)
June 2009
-
-$6.72 M(-13.7%)
-$27.63 M(-5.8%)
Mar 2009
-
-$7.79 M(+61.3%)
-$29.33 M(+3.8%)
Dec 2008
-$28.26 M(-213.8%)
-$4.83 M(-41.8%)
-$28.26 M(+20.4%)
Sept 2008
-
-$8.29 M(-1.6%)
-$23.47 M(-1537.3%)
June 2008
-
-$8.42 M(+25.4%)
$1.63 M(-58.7%)
Mar 2008
-
-$6.72 M(>+9900.0%)
$3.96 M(-84.1%)
Dec 2007
$24.84 M(-351.1%)
-$39.50 K(-100.2%)
$24.84 M(+21.0%)
Sept 2007
-
$16.81 M(-375.6%)
$20.53 M(-3795.1%)
June 2007
-
-$6.10 M(-143.1%)
-$555.70 K(-138.0%)
Mar 2007
-
$14.16 M(-426.0%)
$1.46 M(-114.8%)
Dec 2006
-$9.89 M(-62.3%)
-$4.34 M(+1.6%)
-$9.89 M(-11.2%)
Sept 2006
-
-$4.28 M(+4.8%)
-$11.14 M(-18.8%)
June 2006
-
-$4.08 M(-245.3%)
-$13.71 M(-16.6%)
Mar 2006
-
$2.81 M(-150.3%)
-$16.44 M(-37.4%)
Dec 2005
-$26.25 M(+4.8%)
-$5.59 M(-18.4%)
-$26.25 M(+27.1%)
Sept 2005
-
-$6.85 M(+0.5%)
-$20.66 M(+49.6%)
June 2005
-
-$6.81 M(-2.6%)
-$13.81 M(+97.4%)
Mar 2005
-
-$7.00 M
-$7.00 M
Dec 2004
-$25.04 M
-
-

FAQ

  • What is Catalyst Biosciences annual cash flow from operations?
  • What is the all time high annual CFO for Catalyst Biosciences?
  • What is Catalyst Biosciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Catalyst Biosciences?
  • What is Catalyst Biosciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Catalyst Biosciences?

What is Catalyst Biosciences annual cash flow from operations?

The current annual CFO of CBIO is -$33.10 M

What is the all time high annual CFO for Catalyst Biosciences?

Catalyst Biosciences all-time high annual cash flow from operations is $138.30 M

What is Catalyst Biosciences quarterly cash flow from operations?

The current quarterly CFO of CBIO is -$3.22 M

What is the all time high quarterly CFO for Catalyst Biosciences?

Catalyst Biosciences all-time high quarterly cash flow from operations is $174.35 M

What is Catalyst Biosciences TTM cash flow from operations?

The current TTM CFO of CBIO is -$13.38 M

What is the all time high TTM CFO for Catalyst Biosciences?

Catalyst Biosciences all-time high TTM cash flow from operations is $161.24 M